StockpollyBeta
Get App
Delisting riskPopularity #4,340
ISPC · NASDAQ · Medical - Diagnostics & Research

iSpecimen (ISPC)

Order-driven marketplace for annotated human biospecimens.

$1.26
After hours−0.00 (−0.31%)
At close$1.27(−4.17%)

Something off on this page? Send us feedback.

13F · 13D/G · Form 4

Institutions0.00%0 shares
1 holder · as of Mar 31, 2026
Other100.00%138.9K shares
remainder

138.9K company shares as of Sep 6, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing

Two share counts disagree (2.52M in the company's Sep 22, 2026 report, 138.9K elsewhere); stakes use the report.

13F · 13D/G · Form 4

HolderStakeSharesDate
Gill Capital Partners, LLCInstitution
0.00%15as of Mar 31, 2026
Empery Asset Management, LPInstitution
—5.34% of class, as filed—filed Jan 24, 2022
James G. WolfInsider
—6.13% of class, as filed—filed Sep 28, 2022
Andrew L. Ross1Insiderdirector
1.19%1,658filed May 17, 2023
OBF Investments, LLC2,3Strategic10 percent owner
0.76%1,052filed Jun 23, 2021
George H. Scholl4Insiderdirector
0.76%1,052filed Feb 10, 2023
Christopher Ianelli1Insiderdirector
0.38%532filed May 17, 2023
Jill Mullan1Insiderdirector
0.22%308filed May 17, 2023
Benjamin Bielak5Insiderofficer: Chief Info Officer & Secretary
0.08%105filed Sep 15, 2023
Tracy Curley6Insiderdirector, officer: CEO, CFO and Treasurer
0.04%62filed Jun 1, 2023
John L. III Brooks1Insiderdirector
0.00%4filed May 17, 2023
Steven R. Ph.D. Gullans1Insiderdirector
0.00%4filed May 17, 2023
Joseph J. Basile1Insiderdirector
0.00%0filed May 17, 2023
  1. Last filed May 17, 2023; leaving the company requires no filing. Not in the bar.
  2. Last filed Jun 23, 2021; leaving the company requires no filing. Not in the bar.
  3. Reported at 4.40% on Feb 14, 2025, under the 5% line, so no further filing is required.
  4. Last filed Feb 10, 2023; leaving the company requires no filing. Not in the bar.
  5. Last filed Sep 15, 2023; leaving the company requires no filing. Not in the bar.
  6. Last filed Jun 1, 2023; leaving the company requires no filing. Not in the bar.

13F, as of Mar 31, 2026

1 holder · 15 shares · 1 new position · 1 increased · 0 reduced · 0 closed

HolderShares% outstandingChg q/qFiled
Gill Capital Partners, LLC150.01%+15newApr 13, 2026

13D/G · 5% or more, as filed

No 13D/G filer at 5% or more on record.

Form 4

Latest trades

Nothing filed in the last 12 months.

House and Senate disclosures

Not reported.